Back to search

Article

AKR1C3 Expression in T and B Acute Lymphoblastic Leukemia/Lymphoma for Clinical Use as a Biomarker

2021-11-03

Abstract excerpt

<h4>Objectives: </h4> To investigate aldo–keto reductase 1C3 (AKR1C3) expression in T and B acute lymphoblastic leukemia/lymphoma (ALL) patients. <h4>Methods: </h4>: Three commercial antibodies were evaluated for AKR1C3 immunohistochemistry (IHC) staining performance: Polyclonal Thermofisher scientific (Clone#PA523667), rabbit monoclonal Abcam [EPR16726] (ab209899) and Sigma/Millipore anti-AKR1C3 antibody, mouse m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
09143d9d-e0fb-5f19-8394-651e3b9e44f7
DOI
10.21203/rs.3.rs-1009027/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
AKR1C3 Expression in T and B Acute Lymphoblastic Leukemia/Lymphoma for Clinical Use as a BiomarkerDOI 10.21203/rs.3.rs-1009027/v1
Select a neighboring publication to make it the new centre.